The use of weight-loss jabs may be associated with wider health benefits including lower risk of stroke and dementia, a study ...

Glucagon-like peptide-1 receptor agonists (GLP-1RAs), used to treat diabetes and for weight loss, may be linked with a reduced risk of substance use and neurocognitive disorders, a US study in people ...

It may lower the risk of heart and blood disorders such as deep vein thrombosis and heart attack, as well as neurocognitive ...

The study included nearly 2 million patients, making it the largest ever conducted on this group of glucagon-like peptide-1 ...

A study has suggested that the use of weight-loss jabs may be associated with wider health benefits, including a lower risk ...

According to an article in Reader’s Digest, growing evidence shows that dancing can boost brain health and help manage ...

Harvard experts highlight the broad health benefits of exercise beyond weight loss, even with new diet drugs available.

While weight-loss drugs were linked to lower risk of some conditions, they were also associated with some adverse health ...

GLP-1 agents "have an intricate web of various effects," Al-Aly said in a press briefing. For example, the analysis showed ...

Popular GLP-1 medications approved for weight loss, diabetes, and heart disease may have untapped potential to treat ...

Demand for weight-loss medications sold under brand names such as Ozempic and Wegovy continues to surge, with a study ...

An observational study has uncovered a possible link between taking GLP-1s and increased risk of kidney, pancreas and gut ...